Capital markets

• Advised MedSci Healthcare Holdings Limited on its listing on the Main Board of Hong Kong Stock Exchange (stock code: 2415) (sponsored by CICC and Macquarie)

• Advised Beisen Holding Limited on its listing on the Main Board of Hong Kong Stock Exchange (stock code: 9669) (sponsored by Morgan Stanley and CICC)

• Advised Broncus Holding Corporation on its listing on the Main Board of Hong Kong Stock Exchange (stock code: 2216) (sponsored by Goldman Sachs and Haitong)

• Advised CEBI and SBI China on the listing of AdTiger Corporations Limited on the Main Board of Hong Kong Stock Exchange (stock code: 1163)

• Advised Kintor Pharmaceutical Limited on its listing on the Main Board of Hong Kong Stock Exchange (stock code: 9939) (sponsored by Huatai)

• Advised UBS and CMBI on the listing of Mobvista Inc. on the Main Board of Hong Kong Stock Exchange (stock code: 1860)

• Advised Haitong and DBS on the listing of Beijing Enterprises Urban Resources Group Limited on the Main Board of Hong Kong Stock Exchange (stock code: 3718)

• Advised Shanshan Brand Management Co., Ltd. on its listing on the Main Board of Hong Kong Stock Exchange (stock code: 1749) (sponsored by Dongxing Securities)

• Advised FY Financial (Shenzhen) Co., Ltd. on its listing on the GEM of Hong Kong Stock Exchange (stock code: 8452) (sponsored by Dongxing Securities)

• Advised CCBI and CLSA on the listing of JNBY Design Limited on the Main Board of Hong Kong Stock Exchange (stock code: 3306)

• Advised CITIC CLSA, CICC, Goldman Sachs and ABCI on the listing of China Zheshang Bank Co., Ltd. on the Main Board of Hong Kong Stock Exchange (stock code: 2016)

• Advised Tsaker Chemical Group Limited on its listing on the Main Board of Hong Kong Stock Exchange (stock code: 1986) (sponsored by Haitong)

• Advised Guotai Junan on the spin-off and listing of Chanjet Information Technology Company Limited on the Main Board of Hong Kong Stock Exchange (stock code: 1588)

• Advised Consun Pharmaceutical Group Limited on its listing on the Main Board of Hong Kong Stock Exchange (stock code: 1681) (sponsored by BOCI)

• Advised China Power New Energy Development Company Limited (CPNE) and China Power Clean Energy Development Company Limited (CPCE) (stock code: 735) on the re-domiciliation and reorganization of the holding company of the listed group, from Bermuda-incorporated CPNE to Hong Kong-incorporated CPCE by way of a scheme of arrangement under the Companies Act 1981 of Bermuda

 

Investments and mergers and acquisitions

• Advised Cutia Therapeuties on its US$75 million pre-IPO Series C financing

• Advised CMBC as the subscriber on the subscription of Class D shares of Dao Sheng (Hong Kong) Limited for a consideration of HK$250 million

• Advised ICBCI as the subscriber on the subscription of the convertible promissory note of China Youran Dairy Group Limited in the aggregate principal amount of US$30 million

• Advised Jefferies as the subscriber on the subscription of US$5,000,000 senior unsecured convertible note of Green Monday Holdings Limited

• Advised CCBI as the subscriber on the subscription of series C preferred shares of Youlife Holdings for a consideration of US$16 million

• Advised CCBI as the buyer and investor on the acquisition of approximately 0.6% of the share capital in Miniso Group Holding Limited for a consideration of US$25 million

• Advised Panda Green Energy Group Limited (stock code: 686) on (a) the acquisition of controlling shareholding in Panda Green by Beijing Energy Holding Co., Ltd. by way of share subscription for a consideration of HK$1,794 million and (b) mandatory general offer obligation and whitewash waiver under the Takeovers code

• Advised China Power International Development Limited (stock code: 2380) on its acquisitions of certain clean energy project companies from its controlling shareholders (including State Power Investment Corporation) for an aggregate consideration of approximately RMB5.0 billion

• Advised Swire Beverages Holdings Limited on (a) the acquisitions of certain bottling operations in China from The Coca-Cola Company and (through auction) COFCO Coca-Cola Beverages Limited, (b) the disposal of one bottling unit in China to COFCO Coca-Cola Beverages Limited and (c) the acquisition of a minority interest in Swire Beverages Limited from The Coca-Cola Company

• Advised Zhongshan Ma Er Daily Products Ltd., a leading shower gel and laundry detergent manufacturer in southern China, on the sale of its business to the consumer care arm of Wipro Group, which is a listed Indian conglomerate

• Advised CICC, being the financial adviser to Longevity Investment Holding Limited as purchaser, on the acquisition of a majority interest in Kai Shi China Holdings Company Limited (stock code: 1281) and unconditional mandatory cash offers

 

Post-IPO compliance and general commercial matters

• Advised Tencent Holdings Limited (stock code: 700), Consun Pharmaceutical Group Limited (stock code: 1681), Far East Horizon Limited (stock code: 3360), NagaCorp Ltd. (stock code: 3918), Inke Limited (stock code: 3700), Mobvista Inc. (stock code: 1860) and Huarong Investment Stock Corporation Limited (stock code: 2277) on various compliance matters

• Advised China Shanshui Cement Group Limited (stock code: 691) on its share trading resumption plan

• Advised National Council for Social Security Fund on its various disclosure of interest filings

• Advised CAR Inc. on the management continuity analysis and proposed listing timetable

• Advised Nike on various commercial contracts

 

Other matters

• Advised Mobvista Inc. (stock code: 1860) and its controlling shareholder Seamless Technology Limited on the placing of existing shares and top-up subscription of new shares under General Mandate

• Advised Mobvista Inc. (stock code: 1860) on its issuance of convertible bond in the principal amount of US$30 million to PAGAC

• Advised Seamless Technology Limited on its issuance of convertible bond in the principal amount of US$105 million to PAGAC

• Advised China Power International Development Limited (stock code: 2380) on its rights issue to raise approximately HK$4.5 billion

• Advised Guotai Junan International Holdings Limited (stock code: 1788) on its rights issue

• Advised Honghua Group Limited (stock code: 196) on its issue of shares under specific mandates to China Aerospace Science & Industry Corporation and other institutional investors for an aggregate consideration of approximately HK$1.63 billion

• Advised China High Speed Transmission Equipment Group Co., Ltd. (stock code: 658) on its issuance of CNY denominated guaranteed bonds valued at RMB650 million